Results 221 to 230 of about 5,926,898 (305)

The impact of Choosing Wisely^TM recommendations and insurance coverage restrictions on the provision of low-value care: an interrupted time series analysis of vitamin D tests. [PDF]

BMC Health Serv Res
Sallin A, Ammann D, Bähler C, Müller T, Neuner-Jehle S, Senn O, Blozik E.   +6 more
europepmc   +1 more source

Exploring new avenues: Psychedelic‐assisted therapy for young people

British Journal of Clinical Pharmacology, EarlyView.
Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic‐assisted therapy, using substances such as psilocybin and 3,4‐methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including ...
Ioanna Artemis Vamvakopoulou, Dasha Nicholls, David J. Nutt, Martina Di Simplicio   +3 more
wiley   +1 more source

The cost of dengue shock and septic shock in Vietnam: a patient-centred economic analysis. [PDF]

Int Health
McBride A, Van Hao N, Tho PV, Tai LTH, Phong NT, Ngoc NT, Huyen NA, Hung TM, Llewelyn MJ, Yacoub S, Thwaites L, Turner HC.   +11 more
europepmc   +1 more source

Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?

British Journal of Clinical Pharmacology, EarlyView.
Christina Gao, Ashley M. Hopkins, Andrew Rowland, Stephen Bacchi   +3 more
wiley   +1 more source

Cardiovascular and neuropsychiatric outcomes with PCSK9 inhibitors in atherosclerotic cardiovascular disease: A retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
Study design and main findings. After 1:1 propensity score matching, 60 885 PCSK9 inhibitor users and 60 885 statin‐only users with ASCVD were compared. Kaplan–Meier curves show 12‐month cumulative event‐free survival for MACE, psychiatric disease, and neurodegenerative disease.
Tianshu Gu, Yang Chen, Nan Zhang, Uazman Alam, Riccardo Proietti, Tong Liu, Kang‐Yin Chen, Gregory Y. H. Lip   +7 more
wiley   +1 more source

Overseas health checkup initiatives: perspectives on Vietnam. [PDF]

Environ Occup Health Pract
Indriyati LH, Yoshikawa T, Eitoku M.
europepmc   +1 more source

Utilization of immune checkpoint inhibitors for the treatment of cancer in Scotland, 2018–2024: A national retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aims The aim of the study is to describe the use of immune checkpoint inhibitors (ICIs) for the treatment of cancer in Scotland. Methods The retrospective observational cohort study included patients aged 18 years or older who commenced treatment with an ICI in Scotland between 1 January 2018 and 31 December 2024.
Tanja Mueller, Christine Crearie, Liya Lu, Jiafeng Pan, Fraser N. Sneden, David Martin, Amanj Kurdi, Catherine S. Thomson, Julie Clarke, Marion Bennie   +9 more
wiley   +1 more source

A conceptual framework linking health related costs of PFAS pollution to the polluter pays principle. [PDF]

iScience
Vandamme Z, Reimann B, Vandenbulcke B, Portugaels N, Vanhooff L, Louckx F, Weyts B, Plusquin M, Putman K.   +8 more
europepmc   +1 more source

CONSISTENCY FEATURES OF COMPULSORY AND VOLUNTARY INSURANCE IN SYSTEM OF MEDICAL INSURANCE FINANCIAL PROVISION

Scientific Notes of Ostroh Academy National University, "Economics" Series, 2019
openaire   +2 more sources

Impact of parameter settings on the estimation of drug exposure with the individualized dispensing patterns method

British Journal of Clinical Pharmacology, EarlyView.
Aim To assess the impact of parameter settings when using the individualized dispensing patterns (IDP) method to estimate exposure duration from dispensing data. Methods We conducted a cohort study using a 2% representative sample of the French healthcare insurance database from 2013 to 2022.
Laëtitia Gosselin, Clara Lévy, Noémie Sève, Thierry Blanchon, Marianne Sarazin, Louise Rossignol, Maryse Lapeyre‐Mestre, Nathanaël Lapidus, Olivier Steichen   +8 more
wiley   +1 more source